ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook
May 01, 2024 at 14:55 PM EDT
Eli Lilly and Company posted mixed first-quarter 2024 earnings, beating earnings estimates but lagging on revenues. Investors seeking to tap the opportune moment could bet on ETFs having the largest exposure to the drugmaker.
